26 June 2025 Biotech institute successfully challenges EPO decision revoking key CRISPR patent over priority rights | Appeal ...

Bayer appoints new head of IP ...

French biopharma giant overturns German rival’s patent at the European Patent Office | Revocation based on insufficient ...

This session brings together experts from Choate, Radius Health, and Syros Pharmaceuticals to examine the current policy ...

Biotech institute successfully challenges EPO decision revoking key CRISPR patent over priority rights | Appeal follows major changes to European law | Case returns to lower court for novelty and ...

Insurance company Cigna claims Bristol Myers Squibb may have caused overpayments of ‘billions’ of dollars after allegedly delaying market entry of generic Pomalyst | Lawsuit follows dismissal of ...